FrancophonIA/ELRC3.0 huggingface dataset:
English: In an open label long-term uncontrolled study, the pain reduction in patients responding to 8-weeks of acute treatment of duloxetine 60 mg once daily was maintained for a further 6-months as measured by change on the Brief Pain Inventory (BPI) 24-hour average pain item.
Estonian: Avatud pikaajalises uuringus püsis valu vähenemine, mida mõõdeti muutuse järgi valuküsimustiku (Brief Pain Inventory, BPI) 24-tunni keskmise valu skaalal, järgneva 6 kuu jooksul patsientidel, kes reageerisid esialgsele üks kord ööpäevas 60 mg Duloxetine Mylan'i 8-nädalasele ravile.
English: The most commonly reported adverse reactions in patients treated with duloxetine were nausea, headache, dry mouth, somnolence, and dizziness.
Estonian: Duloxetine Mylan'iga ravitud patsientidel olid kõige sagedamini registreeritud kõrvaltoimeteks iiveldus, peavalu, suukuivus, unisus ja pearinglus.
English: • inflammation of the mouth, passing bright red blood in your stools, bad breath, inflammation of the large intestine (leading to diarrhoea)
Estonian: • suupõletik, helepunanse vere tekkimine väljaheitesse, halb hingeõhk, põletik jämesooles (mis põhjustab kõhulahtisust)
English: Propylene glycol Strong ammonia solution Yellow iron oxide (E172)
Estonian: Ppropüleenglükool Tugev ammoniaagilahus Kollane raudoksiidi (E172)
English: Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function (e.g. NSAIDs or acetylsalicylic acid (ASA)), and in patients with known bleeding tendencies.
Estonian: Antikoagulantide ja/või trombotsüütide funktsiooni mõjustavaid ravimeid (nt MSPVA-d või atsetüülsalitsüülhape ) kasutavate ja veritsustele kalduvate patsientide puhul soovitatakse olla eriti tähelepanelik.
English: Duloxetine Mylan may make you feel sleepy or dizzy.
Estonian: Duloxetine Mylan võib tekitada unisust või uimasust.
English: Suicide-related behaviours (suicide attempts and suicidal thoughts), and hostility (predominantly aggression, oppositional behaviour and anger), were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared to those treated with placebo.
Estonian: Kliinilistes uuringutes täheldati antidepressantidega ravitud laste ja noorukite seas rohkem suitsidaalset käitumist (enesetapukatsed ja suitsidaalsed mõtted) ja vaenulikkust (valdavalt agressiivsus, vastandav käitumine ja viha) kui platseeborühmas.
English: In a relapse prevention study, patients responding to 6 months of acute treatment with open-label duloxetine were randomised to either duloxetine or placebo for a further 6-months.
Estonian: Retsidiivide profülaktika avatud uuringus randomiseeriti patsiendid, kellel esines ravivastus 6kuulisele akuutsele Duloxetine Mylan'i ravile, saama järgmise 6 kuu jooksul kas Duloxetine Mylan'it või platseebot.
English: Use in children and adolescents under 18 years of age Duloxetine Mylan should not be used in the treatment of children and adolescents under the age of 18 years.
Estonian: Duloxetine Mylan'it ei tohi kasutada laste ja alla 18 aasta vanuste noorukite raviks.
English: Caution is advised if Duloxetine Mylan is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Estonian: Kõrgendatud tähelepanu on eriti vajalik siis, kui Duloxetine Mylan'it kasutatakse samaaegselt kitsa terapeutilise indeksiga (nagu flekainiid, propafenoon ja metoprolool) ja peamiselt CYP2D6 abil metaboliseeruvate ravimitega (risperidoon, tritsüklilised antidepressandid [TTA`d] nagu nortriptüliin, amitriptüliin ja imipramiin).
English: Care should be taken if you drink alcohol while you are being treated with Duloxetine Mylan.
Estonian: Teil tuleb Duloxetine Mylan'i ravi ajal olla ettevaatlik alkoholi tarbimisega.
English: The effect of duloxetine 60 mg once a day in elderly depressed patients (≥65 years) was specifically examined in a study that showed a statistically significant difference in the reduction of the HAMD17
Estonian: Manustades vanematele depressiivsetele patsientidele (≥65 aastat) üks kord ööpäevas 60 mg Duloxetine Mylan'it, vaadeldi selle efektiivsust uuringus, mis näitas duloksetiiniga ravitud patsientide puhul võrreldes platseeboga statistiliselt olulist erinevust HAMD 17 skoori vähenemisel.
English: Two randomized, double-blind, parallel clinical trials were performed in 800 paediatric patients aged 7 to 17 years with major depressive disorder (see section 4.2).
Estonian: 800 depressiooni põdeva patsiendiga vanuses 7...17 aastat (vt lõigud 4.2) viidi läbi kaks randomiseeritud topeltpimedat paralleelset uuringut.
English: Two patients who transitioned from placebo to duloxetine after the acute phase experienced suicidal behaviours while taking duloxetine during the extension phase.
Estonian: Kahel platseebogrupist pärast akuutravifaasi duloksetiini gruppi üle viidud patsiendil esines pikendatud ravi faasi ajal duloksetiini võtmisega seoses suitsidaalset käitumist.
English: Stomatitis Haematochezia Breath odour Microscopic colitis
Estonian: Hematokeesia Halb hingeõhk Mikroskoopiline koliit
English: Duloxetine Mylan may be associated with sedation and dizziness.
Estonian: Duloxetine Mylan'i kasutamisega võivad kaasneda sedatsioon ja pearinglus.
English: A total of 509 paediatric patients aged 7 to 17 years with major depressive disorder and 241 paediatric patients aged 7 to 17 years with generalised anxiety disorder were treated with duloxetine in clinical trials.
Estonian: Kliinilises uuringus raviti duloksetiiniga kokku 509 depressiooni diagnoosiga ja 241 generaliseerunud ärevushäire diagnoosiga last vanuses 7...17 aastat.
English: Response and remission rates were also statistically significantly higher with duloxetine compared with placebo.
Estonian: Duloxetine Mylan'il olid platseeboga võrreldes ka statistiliselt oluliselt suuremad ravivastuse ja remissiooni määrad.
English: The dose may be adjusted up to 120 mg a day based on your response to Duloxetine Mylan.
Estonian: Olenevalt sellest, kuidas te Duloxetine Mylan'ile reageerite, võidakse annust suurendada kuni 120 mg-ni ööpäevas.
English: Generalised Anxiety Disorder: Duloxetine demonstrated statistically significant superiority over placebo in five out of five studies including four randomised, double-blind, placebo-controlled acute studies and a relapse prevention study in adult patients with generalised anxiety disorder.
Estonian: Generaliseerunud ärevushäire: Kõigis viies uuringus, mille hulka kuulusid neli randomiseeritud, topeltpimedat, platseeboga kontrollitud akuutset uuringut ja retsidiivide profülaktika uuring täiskasvanud generaliseerunud ärevushäirega patsientidel, leidis tõestust Duloxetine Mylan'i statistiliselt oluline paremus platseeboga võrreldes.
English: When taken during pregnancy, similar drugs (SSRIs) may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear bluish.
Estonian: Seda nimetatakse vastsündinu püsivaks pulmonaarseks hüpertensiooniks, mistõttu teie beebi hingab kiiresti ja muutub sinakaks.
English: b. Tabulated summary of adverse reactions
Estonian: b. Kõrvaltoimete tabelkokkuvõte
English: • feeling sick (nausea), dry mouth
Estonian: • halb enesetunne (iiveldus), suukuivus
English: Opaque blue cap and opaque yellow body approximately 21.7 mm, imprinted in white ink with ‘MYLAN' over ‘DL 60' on both the cap and the body.
Estonian: Läbipaistmatu-sinine kaas ning umbes 21,7 mm läbipaistmatu-kollane keha, nii kaanele kui ka kehale on valge tindiga trükitud „MYLAN“ ja selle all „DL 60“.
English: There was no statistically significant difference in discontinuation due to adverse events between duloxetine and placebo groups during the 10 week acute treatment phase.
Estonian: 10-nädalase akuutravifaasi ajal kõrvaltoimete tõttu ravi katkestamises kahe grupiduloksetiini ja platseebo - vahel statistiliselt olulisi erinevusi ei olnud.
English: Common side effects (may affect up to 1 in 10 people)
Estonian: Sagedased kõrvaltoimed (võivad esineda kuni 1 inimesel 10-st)
English: Duloxetine 60 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.004) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse.
Estonian: Retsidiivini kulunud aja põhjal ilmnes, et 60 mg Duloxetine Mylan'it üks kord ööpäevas omas statistiliselt oluliselt paremat tulemust esmase tulemusnäitaja - depressiooni retsidiivi profülaktika - osas kui platseebo (p=0,004).
English: Stevens-Johnson Syndrome Angio-neurotic oedema
Estonian: Angio-neurootiline ödeem
English: The 60 mg capsules have an opaque blue cap and opaque yellow body, imprinted in white ink with ‘MYLAN' over ‘DL 60' on both the cap and the body.
Estonian: 60 mg kapslid on läbipaistmatu-sinise kaane ja läbipaistmatu-kollase kehaga, millel valge kirjaga „MYLAN“ ja selle all „DL 60“ nii kaanel kui ka kehal.
English: The no-adverse effect level was determined to be 20 mg/kg/day.
Estonian: Ööpäevased annused 20 mg/kg ei mõjutanud kõrvaltoimete taset.
English: Hepatitis Elevated liver enzymes (ALT, AST, alkaline phosphatase) Acute liver injury
Estonian: Maksaensüümide aktiivsuse tõus (ALAT, ASAT, alkaalne fosfataas) Äge maksakahjustus
English: Opaque blue cap and opaque white body approximately 15.9 mm, imprinted in gold ink with ‘MYLAN' over ‘DL 30' on both the cap and the body.
Estonian: Läbipaistmatu-sinine kaas ning umbes 15,9 mm läbipaistmatu-valge keha, nii kaanele kui ka kehale on kuldse tindiga trükitud „MYLAN“ ja selle all „DL 30“.
English: The use of Duloxetine Mylan while breast-feeding is not recommended.
Estonian: Imetamise ajal ei ole Duloxetine Mylan'i kasutamine soovitatav.
English: Major Depressive Disorder and Generalised Anxiety Disorder: Depression is associated with an increased risk of suicidal thoughts, self harm and suicide (suicide-related events).
Estonian: Depressiooniga kaasub suitsidaalsete mõtete tekke, enesekahjustamise ja suitsiidi (suitsidaalse käitumise) suurenenud risk.
English: Galactorrhoea Hyperprolactinaemia Postpartum haemorrhage
Estonian: Hüperprolaktineemia Sünnitusjärgne verejooks
English: The 30 mg capsules have an opaque blue cap and opaque white body, imprinted in gold ink with ‘MYLAN' over ‘DL 30' on both the cap and the body.
Estonian: 30 mg kapslid on läbipaistmatu-sinise kaane ja läbipaistmatu-valge kehaga, millel kuldse kirjaga „MYLAN“ ja selle all „DL 30“ nii kaanel kui ka kehal.
English: 60 mg capsules Each capsule contains 60 mg of duloxetine (as hydrochloride).
Estonian: 60 mg kapslid Iga kapsel sisaldab 60 mg duloksetiini (vesinikkloriidina).
English: PVC/PCTFE/Aluminium or OPA/Aluminium/PVC - Aluminium perforated unit dose blister pack containing 7 x 1, 28 x 1 and 30 x 1 hard gastro-resistant capsules.
Estonian: PVC/PCTFE/alumiinium või OPA/alumiinium/PVC-alumiinium üksikannuselised perforeeritud blistrid, mis sisaldavad 7 x 1, 28 x 1 ja 30 x 1 gastroresistentset kõvakapslit.
English: Caution is advisable if Duloxetine Mylan is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John's wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Estonian: Duloxetine Mylan'i manustamisel koos serotoniinergiliste ainete, nt SSRI-d, SVTI-d, tritsükliliste antidepressantide, nt klomipramiin või amitriptülliin, MAOI-dega, nt moklobemiid või linesoliid, naistepuna ürdiga (Hypericum perforatum) või triptaanidega, tramadooli, petidiini ja trüptofaaniga soovitatakse olla eriti tähelepanelik (vt lõik
English: Duloxetine 60 mg to 120 mg once daily demonstrated statistically significant superiority compared to placebo (p<0.001) on the prevention of relapse, as measured by time to relapse.
Estonian: Retsidiivide profülaktikas, mõõdetuna retsidiivini kulunud aja järgi, ilmnes üks kord ööpäevas 60...120 mg Duloxetine Mylan'il statistiliselt oluline paremus platseeboga (p < 0,001) võrreldes.
English: There have been reports of bleeding abnormalities, such as ecchymoses, purpura and gastrointestinal haemorrhage with selective serotonin reuptake inhibitors (SSRIs) and serotonin/noradrenaline reuptake inhibitors (SNRIs), including duloxetine.
Estonian: Selektiivsete serotoniini tagasihaarde inhibiitoritega (SSRI-tega) ja serotoniini/noradrenaliini tagasihaarde inhibiitoritega (SNRI-tega), sh duloksetiiniga, on esinenud haiguslikke veritsusi, nt ekhümoose, purpurit ja gastrointestinaalset veritsust.
English: • throat inflammation that causes a hoarse voice
Estonian: • kilpnäärme aktiivsuse langus, mis põhjustab väsimust või kehakaalu tõusu
English: Adverse reactions may be more common during concomitant use of Duloxetine Mylan and herbal preparations containing St John's wort (Hypericum perforatum).
Estonian: Duloxetine Mylan'i ja naistepuna (Hypericum perforatum) sisaldavate taimsete preparaatide samaaegsel kasutamisel võib kõrvaltoimeid esineda sagedamini.
English: The usual starting dose of Duloxetine Mylan is 30 mg once a day after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Estonian: Tavaline Duloxetine Mylan'i algannus on 30 mg ööpäevas, mida pärast tõstetakse enamikul patsientidel 60 mg-ni ööpäevas.
English: Pregnancy and breast-feeding
Estonian: Rasedus ja imetamine:
English: 30 mg capsules Each capsule contains 30 mg of duloxetine (as hydrochloride).
Estonian: 30 mg kapslid Iga kapsel sisaldab 30 mg duloksetiini (vesinikkloriidina).
English: Malaise
Estonian: Ängistus
English: Propylene glycol Sodium hydroxide Povidone
Estonian: Propüleenglükool Naatriumhüdroksiii Povidoon
English: PVC/PE/PVdC/Aluminium perforated unit dose blister pack containing 7 x 1 and 28 x 1 hard gastro-resistant capsules.
Estonian: PVC/PE/PVdC/alumiinium üksikannuselised perforeeritud blistrid, mis sisaldavad 7 x 1 ja 28 x 1 gastroresistentset kõvakapslit.
English: Duloxetine Mylan 30 mg hard gastro-resistant capsules Duloxetine Mylan 60 mg hard gastro-resistant capsules duloxetine (as hydrochloride)
Estonian: Duloxetine Mylan 30 mg gastroresistentsed kõvakapslid Duloxetine Mylan 60 mg gastroresistentsed kõvakapslid duloksetiin (vesinikkloriidina)
English: Duloxetine Mylan 30 mg hard gastro-resistant capsules Duloxetine Mylan 60 mg hard gastro-resistant capsules
Estonian: Duloxetine Mylan 30 mg gastroresistentsed kõvakapslid Duloxetine Mylan 60 mg gastroresistentsed kõvakapslid
English: Pharmacokinetic data on duloxetine is limited in patients with mild or moderate renal impairment.
Estonian: Kerge või mõõduka neerupuudulikkusega patsientidelt on andmed duloksetiini farmakokineetika kohta vähesed.
English: Monoamine oxidase inhibitors (MAOIs): You should not take Duloxetine Mylan if you are taking, or have recently taken (within the last 14 days) another antidepressant medicine called a monoamine oxidase inhibitor (MAOI).
Estonian: Monoamiini oksüdaasi inhibiitorid (MAOI): Te ei tohi Duloxetine Mylan'it kasutada koos MAOI-ga ega enne 14 päeva möödumist pärast MAOI ärajätmist.
English: You must wait at least 14 days after you have stopped taking an MAOI before you can take Duloxetine Mylan.
Estonian: Pärast MAOI ärajätmist ja enne Duloxetine Mylan'i kasutamist peate te ootama vähemalt 14 päeva.
English: PVC/PCTFE/Aluminium or OPA/Aluminium/PVC - Aluminium perforated unit dose blister pack containing 28 x 1, 30 x 1 and 100 x 1 hard gastro resistant capsules PVC/PE/PVdC/Aluminium perforated unit dose blister pack containing 28 x 1 hard gastro-resistant capsules.
Estonian: PVC/PCTFE/alumiinium või OPA/alumiinium/PVC-alumiinium üksikannuselised perforeeritud blistrid, mis sisaldavad 28 x 1, 30 x 1 ja 100 x 1 gastroresistentset kõvakapslit.
English: BLISTER INNER CARTON FOR MULTIPACK FOR 60 MG HARD GASTRO RESISTANT CAPSULES, WITHOUT BLUE BOX
Estonian: SISEMINE BLISTERPAKENDEID SISALDAV PAPPKARP MITMIKPAKENDILE, MIS SISALDAB 60 MG GASTRORESISTENTSEID KÕVAKAPSLEID, ILMA SINISE KARBITA
English: BLISTER INNER CARTON FOR MULTIPACK FOR 30 MG HARD GASTRO RESISTANT CAPSULES, WITHOUT BLUE BOX
Estonian: SISEMINE BLISTERPAKENDEID SISALDAV PAPPKARP MITMIKPAKENDILE, MIS SISALDAB 30 MG GASTRORESISTENTSEID KÕVAKAPSLEID, ILMA SINISE KARBITA
English: Gold ink
Estonian: Kuldne trükivärv
English: PVC/PCTFE/Aluminium or OPA/Aluminium/PVC - Aluminium blister pack containing 14, 28, 84, 98 and multipacks containing 98 (2 packs of 49) hard gastro resistant capsules.
Estonian: PVC/PCTFE/alumiiniumblistrid või OPA/alumiinium/PVC-alumiiniumblistrid, mis sisaldavad 14, 28, 84 ja 98 gastroresistentset kõvakapslit, ja mitmikpakendid, mis sisaldavad 98 (2 pakendit 49 kapsliga) gastroresistentset kõvakapslit.
English: Each capsule contains 30 mg or 60 mg of duloxetine (as hydrochloride).
Estonian: Iga kapsel sisaldab 30 või 60 mg duloksetiini (vesinikkloriidina).
English: Eosinophilic pneumonia9
Estonian: Interstitsiaalne kopsuhaigus Eosinofiilne pneumoonia
English: Duloxetine Mylan 60 mg is available in blister packs of 14, 28, 49, 84, 98 and in a multipack of 98 comprising 2 cartons, each containing 49 capsules, in perforated blister packs containing 28 x 1, 30 x 1, and 100 x 1capsules and bottles containing 30, 100, 250 and 500 capsules and a desiccant.
Estonian: Duloxetine Mylan 60 mg on saadaval 14, 28, 49, 84 või 98 kapslit sisaldavates blisterpakendites ja 98 kapslit sisaldavas mitmikpakendis (mis koosneb 2 pappkarbist, millest kummaski on 49 kapslit), 28 x
English: BLISTER OUTER CARTON FOR MULTIPACK FOR 60 MG HARD GASTRO RESISTANT CAPSULES, WITH BLUE BOX
Estonian: VÄLINE BLISTERPAKENDEID SISALDAV PAPPKARP MITMIKPAKENDILE, MIS SISALDAB 60 MG GASTRORESISTENTSEID KÕVAKAPSLEID, SINISES KARBIS
English: BOTTLE CARTON FOR 60 MG HARD GASTRO RESISTANT CAPSULES
Estonian: PUDELI KARP 60 MG GASTRORESISTENTSETELE KÕVAKAPSLITELE
English: 30 mg capsules EU/1/15/1010/001 EU/1/15/1010/002 EU/1/15/1010/003 EU/1/15/1010/004 EU/1/15/1010/005 EU/1/15/1010/006 EU/1/15/1010/007 EU/1/15/1010/008 EU/1/15/1010/009 EU/1/15/1010/010 EU/1/15/1010/021 EU/1/15/1010/022 EU/1/15/1010/023 EU/1/15/1010/024 EU/1/15/1010/025 EU/1/15/1010/026 EU/1/15/1010/027 EU/1/15/1010/028 EU/1/15/1010/037 EU/1/15/1010/038 EU/1/15/1010/041 EU/1/15/1010/042 EU/1/15/1010/043 EU/1/15/1010/044 EU/1/15/1010/045 EU/1/15/1010/046 EU/1/15/1010/047 EU/1/15/1010/048
Estonian: 30 mg kapslid EU/1/15/1010/001 EU/1/15/1010/002 EU/1/15/1010/003 EU/1/15/1010/004 EU/1/15/1010/005 EU/1/15/1010/006 EU/1/15/1010/007 EU/1/15/1010/008 EU/1/15/1010/009 EU/1/15/1010/010 EU/1/15/1010/021 EU/1/15/1010/022 EU/1/15/1010/023 EU/1/15/1010/024 EU/1/15/1010/025 EU/1/15/1010/026 EU/1/15/1010/027 EU/1/15/1010/028 EU/1/15/1010/037 EU/1/15/1010/038 EU/1/15/1010/041 EU/1/15/1010/042 EU/1/15/1010/043 EU/1/15/1010/044
English: BLISTER OUTER CARTON FOR MULTIPACK FOR 30 MG HARD GASTRO RESISTANT CAPSULES, WITH BLUE BOX
Estonian: VÄLINE BLISTERPAKENDEID SISALDAV PAPPKARP MITMIKPAKENDILE, MIS SISALDAB 30 MG GASTRORESISTENTSEID KÕVAKAPSLEID, SINISES KARBIS
English: PVC/PCTFE/Aluminium or OPA/Aluminium/PVC - Aluminium blister pack containing 7, 14, 28, 98 and multipacks containing 98 (2 packs of 49) hard gastro-resistant capsules.
Estonian: PVC/PCTFE/alumiiniumblistrid või OPA/alumiinium/PVC-alumiiniumblistrid, mis sisaldavad 7, 14, 28 ja 98 gastroresistentset kõvakapslit, ja mitmikpakendid, mis sisaldavad 98 (2 pakendit 49 kapsliga) gastroresistentset kõvakapslit.
English: BOTTLE CARTON FOR 30 MG HARD GASTRO RESISTANT CAPSULES
Estonian: PUDELI KARP 30 MG GASTRORESISTENTSETELE KÕVAKAPSLITELE
English: Pollakiuria
Estonian: tõmblused
English: Each capsule contains 30 mg of duloxetine (as hydrochloride).
Estonian: Iga kapsel sisaldab 30 mg duloksetiini (vesinikkloriidina)
English: Duloxetine Mylan 60 mg hard gastro-resistant capsules duloxetine
Estonian: Duloxetine Mylan 60 mg gastroresistentsed kõvakapslid Duloksetiin
English: BLISTER CARTON FOR 30 MG HARD GASTRO RESISTANT CAPSULES
Estonian: KARP 30 MG GASTRORESISTENTSETELE KÕVAKAPSLITELE
English: Gastric lavage may be indicated if performed soon after ingestion or in symptomatic patients.
Estonian: Peatselt pärast ravimi sissevõtmist või sümptomaatilistel patsientidel võib näidustatud olla maoloputus.
English: EU/1/15/1010/016 EU/1/15/1010/017 EU/1/15/1010/018 EU/1/15/1010/019 EU/1/15/1010/020 EU/1/15/1010/029 EU/1/15/1010/030 EU/1/15/1010/031 EU/1/15/1010/032 EU/1/15/1010/033 EU/1/15/1010/034 EU/1/15/1010/035 EU/1/15/1010/036 EU/1/15/1010/039 EU/1/15/1010/040 EU/1/15/1010/049 EU/1/15/1010/050 EU/1/15/1010/051 EU/1/15/1010/052 EU/1/15/1010/053 EU/1/15/1010/054
Estonian: 60 mg kapslid EU/1/15/1010/011 EU/1/15/1010/012 EU/1/15/1010/013 EU/1/15/1010/014 EU/1/15/1010/015 EU/1/15/1010/016 EU/1/15/1010/017 EU/1/15/1010/018 EU/1/15/1010/019 EU/1/15/1010/020 EU/1/15/1010/029 EU/1/15/1010/030 EU/1/15/1010/031 EU/1/15/1010/032 EU/1/15/1010/033 EU/1/15/1010/034 EU/1/15/1010/035 EU/1/15/1010/036 EU/1/15/1010/039 EU/1/15/1010/040 EU/1/15/1010/049 EU/1/15/1010/050 EU/1/15/1010/051 EU/1/15/1010/052 EU/1/15/1010/053 EU/1/15/1010/054
English: PVC/PE/PVdC/Aluminium blister pack containing 7, 14, 28, 49, 98 and multipacks containing 98 (2 packs of 49) hard gastro resistant capsules.
Estonian: PVC/PE/PVdC/alumiiniumblistrid, mis sisaldavad 7, 14, 28, 49 ja 98 gastroresistentset kõvakapslit, ja mitmikpakendid, mis sisaldavad 98 (2 pakendit 49 kapsliga) gastroresistentset kõvakapslit.
English: Response and remission rates were also higher with duloxetine compared to placebo.
Estonian: Platseeboga võrreldes olid Duloxetine Mylan'il ka suuremad ravivastuse ja remissiooni määrad.
English: BLISTER CARTON FOR 60 MG HARD GASTRO RESISTANT CAPSULES
Estonian: KARP 60 MG GASTRORESISTENTSETELE KÕVAKAPSLITELE
English: BOTTLE LABEL FOR 60 MG HARD GASTRO RESISTANT CAPSULES
Estonian: PUDELI SILT 60 MG GASTRORESISTENTSETELE KÕVAKAPSLITELE
English: PVC/PE/PVdC/Aluminium blister pack containing 14, 28, 49, 98 and multipacks containing 98 (2 packs of 49) hard gastro-resistant capsules.
Estonian: PVC/PE/PVdC/alumiiniumblistrid, mis sisaldavad 14, 28, 49 ja 98 gastroresistentset kõvakapslit, ja mitmikpakendid, mis sisaldavad 98 (2 pakendit 49 kapsliga) gastroresistentset kõvakapslit.
English: See section 4.4.
Estonian: 4.7 Toime reaktsioonikiirusele
English: - This medicine has been prescribed for you only.
Estonian: Siiski määrab teile sobiva annuse teie arst.
English: Duloxetine Mylan contains sucrose and sodium
Estonian: Duloxetine Mylan sisaldab sahharoosi ja naatriumi.
English: Palpitations
Estonian: Hepatiit
English: Cases of suicidal ideation and suicidal behaviours have been reported during duloxetine therapy or early after treatment discontinuation (see section 4.4).
Estonian: Suitsiidimõtete ja suitsidaalse käitumise juhtudest on teatatud duloksetiinravi ajal või kohe peale duloksetiinravi lõpetamist (vt lõik 4.4) Eeldatav esinemissagedus on saadud turuletulekujärgsetest ohutusjärelvalve raportitest; platseeboga kontrollitud kliinilistes uuringutes ei ole täheldatud.
English: Suicidal ideation Sleep disorder Bruxism Disorientation Apathy
Estonian: Unehäired Bruksism Orienteerumishäired
English: Duloxetine Mylan 30 mg hard gastro-resistant capsules duloxetine
Estonian: Duloxetine Mylan 30 mg gastroresistentsed kõvakapslid duloksetiin
English: Blood pressure increase Flushing
Estonian: Vaskulaarsed häired Vererõhu tõus Õhetamine
English: Hard gastro-resistant capsules
Estonian: Gastroresistentsed kõvakapslid
English: Breast feeding
Estonian: Naistepuna ürt
English: - If you have any further questions, ask your doctor or pharmacist.
Estonian: Kui te ei ole milleski kindel, pidage nõu oma arsti või apteekriga.